DK0663906T3 - Fremgangsmåde til fremstilling af taxanderivater - Google Patents

Fremgangsmåde til fremstilling af taxanderivater

Info

Publication number: DK0663906T3
Authority: DK; Denmark
Prior art keywords: pct; vii; date; alkyl; alkenyl
Prior art date: 1992-10-05

Application number

DK93921982.0T

Other languages

English (en)

Inventor

Jean-Manuel Mas

Viviane Charriere B Massonneau

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-05

Filing date

1993-10-04

Publication date

1996-12-30

1993-10-04 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1996-12-30 Application granted granted Critical

1996-12-30 Publication of DK0663906T3 publication Critical patent/DK0663906T3/da

Links

238000000034 method Methods 0.000 title abstract 2
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 2
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 abstract 1
YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 abstract 1
OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 abstract 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000010933 acylation Effects 0.000 abstract 1
238000005917 acylation reaction Methods 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
150000001412 amines Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
150000001602 bicycloalkyls Chemical group 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
230000032050 esterification Effects 0.000 abstract 1
238000005886 esterification reaction Methods 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epoxy Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

DK93921982.0T 1992-10-05 1993-10-04 Fremgangsmåde til fremstilling af taxanderivater DK0663906T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9211741A FR2696458B1 (fr)	1992-10-05	1992-10-05	Procédé de préparation de dérivés du taxane.

Publications (1)

Publication Number	Publication Date
DK0663906T3 true DK0663906T3 (da)	1996-12-30

Family

ID=9434119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93921982.0T DK0663906T3 (da)	1992-10-05	1993-10-04	Fremgangsmåde til fremstilling af taxanderivater

Country Status (24)

Country	Link
US (3)	US5616739A (da)
EP (1)	EP0663906B1 (da)
JP (1)	JP3014760B2 (da)
KR (1)	KR100311198B1 (da)
AT (1)	ATE146174T1 (da)
AU (1)	AU689080B2 (da)
CA (1)	CA2146250C (da)
CZ (1)	CZ283261B6 (da)
DE (1)	DE69306591T2 (da)
DK (1)	DK0663906T3 (da)
ES (1)	ES2095081T3 (da)
FI (1)	FI109793B (da)
FR (1)	FR2696458B1 (da)
GR (1)	GR3021997T3 (da)
HU (1)	HU226412B1 (da)
MX (1)	MX9305766A (da)
NO (1)	NO309089B1 (da)
NZ (1)	NZ256445A (da)
PL (1)	PL182284B1 (da)
RU (1)	RU2116303C1 (da)
SK (1)	SK280627B6 (da)
TW (1)	TW419472B (da)
WO (1)	WO1994007877A1 (da)
ZA (1)	ZA937318B (da)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2696464B1 (fr) *	1992-10-05	1994-11-10	Rhone Poulenc Rorer Sa	Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
FR2697522B1 (fr) *	1992-10-30	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
FR2698361B1 (fr) *	1992-11-20	1995-01-13	Rhone Poulenc Rorer Sa	Procédé de préparation d'un acide oxazolidine-1,3 carboxylique-5.
MX9307777A (es)	1992-12-15	1994-07-29	Upjohn Co	7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
US5973160A (en) *	1992-12-23	1999-10-26	Poss; Michael A.	Methods for the preparation of novel sidechain-bearing taxanes
EP0703909B1 (en) *	1993-06-11	2000-04-26	PHARMACIA & UPJOHN COMPANY	Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
FR2706457B1 (fr) *	1993-06-16	1995-07-28	Rhone Poulenc Rorer Sa	Procédé de préparation d'un acide oxazolidinecarboxylique utile pour préparer des taxoïdes thérapeutiquement actifs.
US6005120A (en)	1993-07-20	1999-12-21	Florida State University	Tricyclic and tetracyclic taxanes
AU698625B2 (en) *	1993-11-12	1998-11-05	Pharmacia & Upjohn Company	Pyrimidine-thioalkyl and alkylether compounds
IL127598A (en) *	1994-01-28	2003-04-10	Upjohn Co	Process for preparing isotaxol analogs
US5679807A (en) *	1995-01-30	1997-10-21	Hauser, Inc.	Preparation of taxol and docetaxel through primary amines
CA2170661A1 (en)	1995-03-22	1996-09-23	John K. Thottathil	Novel methods for the preparation of taxanes using oaxzolidine intermediates
GB9512471D0 (en) *	1995-06-20	1995-08-23	Pharmacia Spa	Method for the preparation of taxol and its derivatives
US5688977A (en) *	1996-02-29	1997-11-18	Napro Biotherapeutics, Inc.	Method for docetaxel synthesis
JP2000510832A (ja) *	1996-05-08	2000-08-22	ファルマシア・アンド・アップジョン・カンパニー	タキソールの製法
US7288665B1 (en) *	1997-08-18	2007-10-30	Florida State University	Process for selective derivatization of taxanes
EP1019347B1 (en) *	1997-08-21	2003-03-19	Florida State University	Method for the synthesis of taxanes
AU1712899A (en) *	1997-12-23	1999-07-12	Bristol-Myers Squibb Company	7-deoxy-6-nitrogen substituted paclitaxels
EP1229934B1 (en)	1999-10-01	2014-03-05	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2002024179A2 (en) *	2000-09-22	2002-03-28	Bristol-Myers Squibb Company	Method for reducing toxicity of combined chemotherapies
US6891050B2 (en) *	2001-08-10	2005-05-10	Dabur India Limited	Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) *	2002-02-05	2005-04-19	Dabur India Limited	Process of purification of paclitaxel and docetaxel
US7247738B2 (en) *	2002-05-07	2007-07-24	Dabur India Limited	Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) *	2002-05-10	2005-05-31	Dabur India Limited	Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US7351542B2 (en)	2002-05-20	2008-04-01	The Regents Of The University Of California	Methods of modulating tubulin deacetylase activity
DK2286795T3 (da)	2002-06-26	2017-02-06	Syncore Biotechnology Co Ltd	Fremgangsmåde til fremstilling af et kationisk liposomalt præparat omfattende en lipofil forbindelse
CN1703409A (zh) *	2002-10-09	2005-11-30	加拿大植原药物公司	新紫杉烷和用途及制备方法
US6838569B2 (en)	2002-12-16	2005-01-04	Dabur India Limited	Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
CN101039957A (zh)	2003-05-16	2007-09-19	因特缪恩公司	合成的趋化因子受体配体及其使用方法
WO2005040758A2 (en) *	2003-10-24	2005-05-06	Intermune, Inc.	Use of pirfenidone in therapeutic regimens
US7202370B2 (en) *	2003-10-27	2007-04-10	Conor Medsystems, Inc.	Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
US7597884B2 (en)	2004-08-09	2009-10-06	Alios Biopharma, Inc.	Hyperglycosylated polypeptide variants and methods of use
KR20070085227A (ko) *	2004-08-09	2007-08-27	앨리오스 바이오파마 인크.	합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
EP1647552A1 (en) *	2004-10-08	2006-04-19	INDENA S.p.A.	Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
EP1712552A1 (en) *	2005-04-11	2006-10-18	INDENA S.p.A.	Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
US7446126B2 (en) *	2004-10-08	2008-11-04	Indena S.P.A.	Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
WO2006089209A2 (en) *	2005-02-17	2006-08-24	The Board Of Trustees Of The Leland Stanford Junior University	Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
US20100160653A1 (en) *	2006-03-21	2010-06-24	Dr. Reddy's Laboratories Ltd.	Docetaxel polymorphs and processes
US8168216B2 (en)	2006-03-22	2012-05-01	Medigene Ag	Treatment of triple receptor negative breast cancer
ITMI20062479A1 (it) *	2006-12-21	2008-06-22	Indena Spa	Processo per la preparazione di secotassani
EP2296645B1 (en)	2008-05-22	2014-11-19	Galera Therapeutics, LLC	Combination antitumor therapy
KR101003822B1 (ko)	2008-06-20	2010-12-27	주식회사 셀트리온화학연구소	도세탁셀의 제조방법 및 도세탁셀의 제조를 위한 신규한중간체
US20110172293A1 (en)	2008-07-08	2011-07-14	Fish Jason E	Methods and Compositions for Modulating Angiogenesis
CN101735179B (zh) *	2008-11-19	2012-09-12	上海百灵医药科技有限公司	一种多烯紫杉醇的制备方法，其中间体及制备方法
EP2358693A4 (en) *	2008-11-20	2012-04-18	Reddys Lab Ltd Dr	PREPARATION OF DOCETAXEL
PL388144A1 (pl)	2009-05-29	2010-12-06	Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością	Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
IN2015DN00552A (da)	2012-07-19	2015-06-26	Redwood Bioscience Inc
AU2013341711A1 (en)	2012-11-12	2015-05-21	Redwood Bioscience, Inc.	Compounds and methods for producing a conjugate
KR102332790B1 (ko)	2013-02-15	2021-12-01	더 리젠츠 오브 더 유니버시티 오브 캘리포니아	키메라 항원 수용체 및 이의 이용 방법
WO2014160185A2 (en)	2013-03-14	2014-10-02	The Board Of Trustees Of The Leland Stanford Junior University	Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
AU2014354643B2 (en)	2013-11-27	2020-03-05	Redwood Bioscience, Inc.	Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
CA2940269C (en)	2014-02-19	2022-08-16	Aviv Therapeutics, Inc.	Mitochondrial aldehyde dehydrogenase 2 (aldh2) binding polycyclic amides and their use for the treatment of cancer
KR20220025946A (ko)	2014-03-21	2022-03-03	애브비 인코포레이티드	항-ｅｇｆｒ 항체 및 항체 약물 접합체
US10654875B2 (en)	2015-11-12	2020-05-19	The Board Of Trustees Of The Leland Stanford Junior University	Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
TWI760319B (zh)	2015-12-30	2022-04-11	杏國新藥股份有限公司	乳癌治療
EP3231421A1 (en)	2016-04-11	2017-10-18	Greenaltech, S.L.	Uses of a carotenoid in the treatment or prevention of stress induced conditions
EP3448885A4 (en)	2016-04-26	2020-01-08	R.P. Scherer Technologies, LLC	ANTIBODY CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF
KR102783452B1 (ko)	2016-06-01	2025-03-19	세르비에 아이피 유케이 리미티드	폴리알킬렌 옥시드-아스파라기나제의 제형, 및 그의 제조 및 사용 방법
EP3469000A1 (en)	2016-06-08	2019-04-17	AbbVie Inc.	Anti-b7-h3 antibodies and antibody drug conjugates
EP3835322A3 (en)	2016-06-08	2021-10-06	AbbVie Inc.	Anti-b7-h3 antibodies and antibody drug conjugates
CN109562169A (zh)	2016-06-08	2019-04-02	艾伯维公司	抗cd98抗体及抗体药物偶联物
WO2017214322A1 (en)	2016-06-08	2017-12-14	Abbvie Inc.	Anti-b7-h3 antibodies and antibody drug conjugates
CN109562168A (zh)	2016-06-08	2019-04-02	艾伯维公司	抗cd98抗体及抗体药物偶联物
TWI852903B (zh)	2017-01-05	2024-08-21	杏國新藥股份有限公司	胰臟癌治療
AU2018211081B2 (en)	2017-01-18	2025-01-02	Bioatla, Inc.	Chimeric antigen receptors against Axl or Ror2 and methods of use thereof
EP3388082A1 (en)	2017-04-13	2018-10-17	Galera Labs, LLC	Combination cancer immunotherapy with pentaaza macrocyclic ring complex
CN118652192A (zh)	2017-05-24	2024-09-17	德克萨斯州大学系统董事会	用于抗体药物缀合物的接头
CN111902147A (zh)	2018-01-31	2020-11-06	加莱拉实验室有限责任公司	五氮杂大环状环配合物和基于铂的抗癌剂的组合癌症治疗
CA3096202A1 (en)	2018-04-06	2019-10-10	The Regents Of The University Of California	Methods of treating egfrviii expressing glioblastomas
EP3773633A4 (en)	2018-04-06	2022-01-26	The Regents of The University of California	METHODS OF TREATMENT OF GLIOBLASTOMA
KR20210009315A (ko)	2018-04-11	2021-01-26	오하이오 스테이트 이노베이션 파운데이션	안약 전달용 서방형 마이크로 입자를 이용한 방법 및 조성물
US11897928B2 (en)	2018-07-18	2024-02-13	Manzanita Pharmaceuticals, Inc.	Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
KR20220004653A (ko)	2019-04-02	2022-01-11	켄조케티 바이오테크놀러지 인코포레이티드	유출 펌프-암 항원 다중특이적 항체 및 그것과 관련된 조성물, 시약, 키트 및 방법
BR112022013870A2 (pt)	2020-01-29	2022-09-13	Kenjockety Biotechnology Inc	Anticorpos anti-mdr1 e usos dos mesmos
US20230212305A1 (en)	2020-06-04	2023-07-06	Kenjockety Biotechnology, Inc.	Anti-abcg2 antibodies and uses thereof
WO2021247423A1 (en)	2020-06-04	2021-12-09	Kenjockety Biotechnology, Inc.	Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
JP7747741B2 (ja)	2020-09-02	2025-10-01	ウィリアムロバートアラスーンリビングトラストデイテッドオーガスト 29, 2016	抗ａｂｃｃ１抗体及びその使用
US20240010747A1 (en)	2020-11-13	2024-01-11	Kenjockety Biotechnology, Inc.	Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
JP2023551203A (ja)	2020-11-20	2023-12-07	アール．ピー．シェーラーテクノロジーズ、エルエルシー	抗体－薬物コンジュゲートのためのグリコシド二重切断リンカー
AR124681A1 (es)	2021-01-20	2023-04-26	Abbvie Inc	Conjugados anticuerpo-fármaco anti-egfr
WO2023114658A1 (en)	2021-12-13	2023-06-22	Kenjockety Biotechnology, Inc.	Anti-abcb1 antibodies
WO2023159220A1 (en)	2022-02-18	2023-08-24	Kenjockety Biotechnology, Inc.	Anti-cd47 antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5175315A (en) *	1989-05-31	1992-12-29	Florida State University	Method for preparation of taxol using β-lactam
US5015744A (en) *	1989-11-14	1991-05-14	Florida State University	Method for preparation of taxol using an oxazinone
US5136060A (en) *	1989-11-14	1992-08-04	Florida State University	Method for preparation of taxol using an oxazinone
MX9102128A (es) *	1990-11-23	1992-07-08	Rhone Poulenc Rorer Sa	Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5319112A (en) *	1992-08-18	1994-06-07	Virgnia Tech Intellectual Properties, Inc.	Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol

1992
- 1992-10-05 FR FR9211741A patent/FR2696458B1/fr not_active Expired - Lifetime
1993
- 1993-09-21 MX MX9305766A patent/MX9305766A/es unknown
- 1993-10-01 ZA ZA937318A patent/ZA937318B/xx unknown
- 1993-10-02 TW TW082108117A patent/TW419472B/zh not_active IP Right Cessation
- 1993-10-04 RU RU95113717A patent/RU2116303C1/ru active
- 1993-10-04 CA CA002146250A patent/CA2146250C/fr not_active Expired - Lifetime
- 1993-10-04 HU HU9500971A patent/HU226412B1/hu unknown
- 1993-10-04 WO PCT/FR1993/000967 patent/WO1994007877A1/fr not_active Ceased
- 1993-10-04 NZ NZ256445A patent/NZ256445A/en not_active IP Right Cessation
- 1993-10-04 KR KR1019950701302A patent/KR100311198B1/ko not_active Expired - Lifetime
- 1993-10-04 AU AU51150/93A patent/AU689080B2/en not_active Expired
- 1993-10-04 SK SK436-95A patent/SK280627B6/sk not_active IP Right Cessation
- 1993-10-04 DE DE69306591T patent/DE69306591T2/de not_active Expired - Lifetime
- 1993-10-04 ES ES93921982T patent/ES2095081T3/es not_active Expired - Lifetime
- 1993-10-04 PL PL93308241A patent/PL182284B1/pl unknown
- 1993-10-04 AT AT93921982T patent/ATE146174T1/de active
- 1993-10-04 CZ CZ95841A patent/CZ283261B6/cs not_active IP Right Cessation
- 1993-10-04 DK DK93921982.0T patent/DK0663906T3/da active
- 1993-10-04 US US08/411,692 patent/US5616739A/en not_active Expired - Lifetime
- 1993-10-04 JP JP6508787A patent/JP3014760B2/ja not_active Expired - Lifetime
- 1993-10-04 EP EP93921982A patent/EP0663906B1/fr not_active Expired - Lifetime
1995
- 1995-03-29 NO NO951201A patent/NO309089B1/no not_active IP Right Cessation
- 1995-04-04 FI FI951595A patent/FI109793B/fi not_active IP Right Cessation
1996
- 1996-10-31 US US08/742,101 patent/US5677462A/en not_active Expired - Lifetime
- 1996-12-12 GR GR960402201T patent/GR3021997T3/el unknown
1997
- 1997-08-08 US US08/908,806 patent/US5869680A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH08501788A (ja)	1996-02-27
DE69306591D1 (de)	1997-01-23
NZ256445A (en)	1997-01-29
CZ283261B6 (cs)	1998-02-18
KR100311198B1 (ko)	2002-04-24
CA2146250A1 (fr)	1994-04-14
GR3021997T3 (en)	1997-03-31
PL182284B1 (pl)	2001-12-31
HU9500971D0 (en)	1995-06-28
JP3014760B2 (ja)	2000-02-28
AU5115093A (en)	1994-04-26
KR950703546A (ko)	1995-09-20
US5616739A (en)	1997-04-01
PL308241A1 (en)	1995-07-24
US5869680A (en)	1999-02-09
ZA937318B (en)	1994-04-25
EP0663906A1 (fr)	1995-07-26
HUT72679A (en)	1996-05-28
EP0663906B1 (fr)	1996-12-11
FR2696458B1 (fr)	1994-11-10
CA2146250C (fr)	2003-03-11
ATE146174T1 (de)	1996-12-15
FI109793B (fi)	2002-10-15
DE69306591T2 (de)	1997-04-17
FI951595A0 (fi)	1995-04-04
SK43695A3 (en)	1995-08-09
HU226412B1 (en)	2008-11-28
CZ84195A3 (en)	1995-09-13
FI951595L (fi)	1995-04-04
ES2095081T3 (es)	1997-02-01
NO309089B1 (no)	2000-12-11
MX9305766A (es)	1995-01-31
NO951201D0 (no)	1995-03-29
NO951201L (no)	1995-03-29
US5677462A (en)	1997-10-14
RU2116303C1 (ru)	1998-07-27
RU95113717A (ru)	1996-12-27
SK280627B6 (sk)	2000-05-16
AU689080B2 (en)	1998-03-26
FR2696458A1 (fr)	1994-04-08
TW419472B (en)	2001-01-21
WO1994007877A1 (fr)	1994-04-14

Publication	Publication Date	Title
DK0663906T3 (da)	1996-12-30	Fremgangsmåde til fremstilling af taxanderivater
ATE147735T1 (de)	1997-02-15	Verfahren zur herstellung von taxan-derivaten
ATE148882T1 (de)	1997-02-15	Verfahren zur herstellung von taxan-derivaten
GR3022286T3 (en)	1997-04-30	Novel method of esterification of baccatine iii an 10-deacetylbaccatine iii.